Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues.
Cozzi R, Ambrosio MR, Attanasio R, Bozzao A, De Marinis L, De Menis E, Guastamacchia E, Lania A, Lasio G, Logoluso F, Maffei P, Poggi M, Toscano V, Zini M, Chanson P, Katznelson L. Cozzi R, et al. Among authors: poggi m. Endocr Metab Immune Disord Drug Targets. 2020;20(8):1144-1155. doi: 10.2174/1871530320666200129113328. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31995025 Free PMC article. Review.
Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L. Baldelli R, et al. Among authors: poggi m. J Endocrinol Invest. 2005 Feb;28(2):157-61. doi: 10.1007/BF03345359. J Endocrinol Invest. 2005. PMID: 15887862
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.
Bianchi A, Valentini F, Iuorio R, Poggi M, Baldelli R, Passeri M, Giampietro A, Tartaglione L, Chiloiro S, Appetecchia M, Gargiulo P, Fabbri A, Toscano V, Pontecorvi A, De Marinis L. Bianchi A, et al. Among authors: poggi m. J Exp Clin Cancer Res. 2013 Jun 21;32(1):40. doi: 10.1186/1756-9966-32-40. J Exp Clin Cancer Res. 2013. PMID: 23799893 Free PMC article.
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry.
Losa M, Beck-Peccoz P, Aimaretti G, Di Somma C, Ambrosio MR, Ferone D, Giampietro A, Corsello SM, Poggi M, Scaroni C, Jia N, Mossetto G, Cannavò S, Rochira V. Losa M, et al. Among authors: poggi m. Clin Endocrinol (Oxf). 2015 Oct;83(4):527-35. doi: 10.1111/cen.12839. Epub 2015 Jul 31. Clin Endocrinol (Oxf). 2015. PMID: 26119712 Clinical Trial.
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS).
Rochira V, Mossetto G, Jia N, Cannavo S, Beck-Peccoz P, Aimaretti G, Ambrosio MR, Di Somma C, Losa M, Ferone D, Lubrano C, Scaroni C, Giampietro A, Corsello SM, Poggi M. Rochira V, et al. Among authors: poggi m. J Endocrinol Invest. 2018 Nov;41(11):1259-1266. doi: 10.1007/s40618-018-0860-x. Epub 2018 Mar 13. J Endocrinol Invest. 2018. PMID: 29536433 Free PMC article.
225 results